Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
1 hedge funds and large institutions have $66K invested in Medicines Co in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 278 closing their positions.
100% less funds holding
Funds holding: 284 → 1 (-283)
100% less funds holding in top 10
Funds holding in top 10: 38 → 0 (-38)
100% less capital invested
Capital invested by funds: $8.36B → $66K (-$8.36B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 278
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.03B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$648M |
| 3 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$357M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$330M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$282M |
MDCO Hedge Fund Activity: Q1 2020 in Review
1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2020, worth a combined $66K — down 100% from $8.36B a quarter earlier.
Sellers outnumbered buyers: 278 funds closed out of MDCO and 0 opened new positions — a net loss of 278 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $1.03B sold.
- 1 institutional investor held Medicines Co (MDCO) as of Q1 2020, down from 284 in Q4 2019.
- Funds reported $66K of Medicines Co stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new Medicines Co positions in Q1 2020 and 278 closed out, a net change of -278 holders.
- The largest Medicines Co seller in Q1 2020 was BlackRock, an estimated $1.03B sold.
Based on aggregated 13F filings for Q1 2020.